Buyer Name: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Buyer Address: 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB, United Kingdom
Contact Email: Holly.bryce@nhs.scot
Contact Telephone: +44 1312756000
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Buyer Name: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Buyer Address: 1 South Gyle Crescent, Edinburgh, UKM, EH12 9EB, United Kingdom
Contact Email: Holly.bryce@nhs.scot
Contact Telephone: +44 1312756000
Supply of Emicizumab (Indication Specific) to NHS Scotland.
No linked documents found for this notice.
Lot Description: The Framework Agreement is for the supply of Emicizumab (Indication Specific) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Lot 1 Has Options: No
{
"awards": [
{
"id": "057742-2025-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-3470",
"name": "Roche Products Ltd"
}
]
}
],
"buyer": {
"id": "GB-FTS-115937",
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"contracts": [
{
"awardID": "057742-2025-1",
"dateSigned": "2025-08-27T00:00:00+01:00",
"id": "057742-2025-1",
"status": "active",
"value": {
"amount": 3120312,
"currency": "GBP"
}
}
],
"date": "2025-09-18T14:24:42+01:00",
"description": "(SC Ref:810514)",
"id": "057742-2025",
"initiationType": "tender",
"language": "en",
"links": [
{
"href": "https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000810514",
"rel": "canonical"
}
],
"ocid": "ocds-h6vhtk-059d38",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Edinburgh",
"postalCode": "EH12 9EB",
"region": "UKM",
"streetAddress": "1 South Gyle Crescent"
},
"contactPoint": {
"email": "Holly.bryce@nhs.scot",
"telephone": "+44 1312756000"
},
"details": {
"buyerProfile": "https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883",
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "http://www.nss.nhs.scot/browse/procurement-and-logistics"
},
"id": "GB-FTS-115937",
"identifier": {
"legalName": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)"
},
"name": "The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Welwyn Garden City",
"postalCode": "AL7 1TW",
"region": "UK",
"streetAddress": "6 Falcon Way, Shire Park"
},
"details": {
"scale": "large"
},
"id": "GB-FTS-3470",
"identifier": {
"legalName": "Roche Products Ltd"
},
"name": "Roche Products Ltd",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Edinburgh",
"postalCode": "EH1 1LB",
"streetAddress": "27 Chambers Street"
},
"contactPoint": {
"email": "edinburgh@scotcourts.gov.uk",
"telephone": "+44 1312252525"
},
"id": "GB-FTS-324",
"identifier": {
"legalName": "Sheriff Court House"
},
"name": "Sheriff Court House",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "Supply of Emicizumab (Indication Specific) to NHS Scotland.",
"id": "ocds-h6vhtk-059d38",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKM"
}
],
"deliveryLocation": {
"description": "All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant\nto the new Public Bodies (Joint Working) Scotland Act 2014"
},
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"description": "The Framework Agreement is for the supply of Emicizumab (Indication Specific) to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.",
"hasOptions": false,
"id": "1"
}
],
"mainProcurementCategory": "goods",
"procurementMethod": "limited",
"procurementMethodDetails": "Negotiated without publication of a contract notice",
"procurementMethodRationale": "Competition for some of the medicines awarded to the Framework Agreement is absent for technical reasons, in accordance with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.\nSome of the medicines awarded to the Framework Agreement are protected by exclusive rights, including intellectual property rights, in accordance with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.",
"procurementMethodRationaleClassifications": [
{
"description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights",
"id": "D_PROTECT_RIGHTS",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"reviewDetails": "Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts:\nAn economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session.\nThe bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.",
"status": "complete",
"techniques": {
"hasFrameworkAgreement": true
},
"title": "NP47725a Emicizumab (Indication Specific)"
}
}